Home › Asset managers › Compare 2025-2026 › Vanguard vs ProShares
Vanguard 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 28,006 | 24,535 | 1,631 | 1,840 | 93.8% | 91.0% |
| Board proposals | 25,558 | 22,454 | 1,535 | 1,569 | 93.6% | 91.1% |
| E&S shareholder proposals | 171 | 137 | 13 | 21 | 91.3% | 87.1% |
| Other items | 2,277 | 1,944 | 83 | 250 | 95.9% | 90.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,569 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | ProShares |
|---|---|---|---|---|---|---|
| CITIGROUP INC. | May 20, 2026 | Proposal to ratify the selection of KPMG LLP as Citi's independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 34 FOR, 9 AGAINST |
FOR 20 funds |
| CITIZENS FINANCIAL SERVICES, INC. | April 21, 2026 | Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | Split 10 FOR, 1 AGAINST |
AGAINST 9 funds |
| CIVISTA BANCSHARES, INC. | May 19, 2026 | To consider and vote upon a non-binding advisory resolution to approve the compensation of the Corporation's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | Split 11 FOR, 1 AGAINST |
AGAINST 9 funds |
| CIVITAS RESOURCES, INC. | January 27, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Civitas' named executive officers in connection with the mergers (as defined in the joint proxy statement/prospectus). Say-on-Pay |
Board | For | Split 24 FOR, 1 AGAINST |
FOR 8 funds |
| CLARITEV CORPORATION | April 29, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 11 FOR, 1 AGAINST |
AGAINST 5 funds |
| CLARUS CORPORATION | May 28, 2026 | To approve an advisory resolution on executive compensation; Say-on-Pay |
Board | For | Split 8 FOR, 1 AGAINST |
AGAINST 9 funds |
| CLEAR SECURE, INC. | June 10, 2026 | Approval of, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 31 FOR, 2 AGAINST |
AGAINST 12 funds |
| CLEARPOINT NEURO, INC. | May 20, 2026 | Approval of ClearPoint Neuro, Inc.'s Seventh Amended and Restated 2013 Incentive Compensation Plan. Compensation |
Board | For | Split 8 FOR, 1 AGAINST |
AGAINST 9 funds |
| CLEARWATER ANALYTICS HOLDINGS, INC. | May 6, 2026 | To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. Say-on-Pay |
Board | For | Split 16 FOR, 2 AGAINST |
FOR 9 funds |
| CLEARWAY ENERGY, INC. | April 29, 2026 | To approve a Second Amended and Restated Certificate of Incorporation of Clearway Energy, Inc. (the "Amended Charter") that would (i) provide that each share of Class A common stock, par value $0.01 per share ("Class A common stock"), will be convertible into one share of Class C common stock, par value $0.01 per share, (ii) provide that such conversion (the "Class A Conversion") will occur automatically at 12:01 A.M. (Eastern Time) on the second business day following the filing of the Amended Charter, (iii) provide that, from and after the Class A Conversion, Clearway Energy, Inc. will not have authority to issue or reissue Class A common stock and certain provisions relating to the Class A common stock will have no further force or effect, (iv) reduce the number of authorized shares of Class A common stock to 34,613,853 and (v) update certain other historical matters. Capital Structure |
Board | For | Split 16 FOR, 6 AGAINST |
FOR 3 funds |
| CLEARWAY ENERGY, INC. | April 29, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as Clearway Energy, Inc.'s independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | Split 16 FOR, 6 AGAINST |
FOR 3 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of amendments to provide for the equal treatment of shares of Class A common stock, Class B common stock, and Class C common stock in connection with dividends and distributions, certain transactions, and upon our liquidation, dissolution, or winding up. Capital Structure |
Board | For | Split 7 FOR, 20 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval and adoption of an amendment and restatement of our amended and restated certificate of incorporation. Approval and adoption of amendments to establish the Class C common stock. Capital Structure |
Board | For | Split 2 FOR, 19 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan. Compensation |
Board | For | Split 21 AGAINST, 2 ABSTAIN |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan. Compensation |
Board | For | Split 20 FOR, 10 AGAINST |
AGAINST 4 funds |
| CLOUDFLARE, INC. | June 30, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 32 FOR, 4 AGAINST |
AGAINST 4 funds |
| CME GROUP INC. | June 9, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 42 FOR, 1 AGAINST |
FOR 19 funds |
| CMS ENERGY CORPORATION | May 8, 2026 | Approve an Amendment to the Restated Articles of Incorporation Increasing the Number of Authorized Shares of Common Stock from 350 Million Shares to 700 Million Shares. Capital Structure |
Board | For | Split 26 FOR, 10 AGAINST |
FOR 18 funds |
| CNH INDUSTRIAL N V | May 8, 2026 | Approval of executive compensation ("say-on-pay") (advisory vote) Say-on-Pay |
Board | For | Split 24 FOR, 7 AGAINST |
FOR 8 funds |
| CNH INDUSTRIAL N V | May 8, 2026 | Ratification of the re-appointment of Deloitte & Touche LLP as our independent registered public accounting firm to audit our 2026 U.S. GAAP financial statements (advisory vote) Audit-related |
Board | For | Split 20 FOR, 7 AGAINST |
FOR 8 funds |
| CNH INDUSTRIAL N V | May 8, 2026 | Re-Appointment of Deloitte Accountants B.V. as the Independent Auditor of the Company's 2026 Dutch Statutory Annual Accounts Audit-related |
Board | For | Split 20 FOR, 7 AGAINST |
FOR 8 funds |
| COCA-COLA EUROPACIFIC PARTNERS | May 28, 2026 | RE-ELECT JOSE IGNACIO COMENGE AS DIRECTOR Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 8 funds |
| COCA-COLA EUROPACIFIC PARTNERS | May 28, 2026 | RE-ELECT MANOLO ARROYO AS DIRECTOR Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 8 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares. Compensation |
Board | For | Split 12 FOR, 12 AGAINST |
AGAINST 14 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To hold an advisory vote to approve named executive officer compensation. Compensation |
Board | For | Split 7 FOR, 20 AGAINST |
AGAINST 14 funds |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | Split 7 FOR, 1 AGAINST |
AGAINST 10 funds |
| COLGATE-PALMOLIVE COMPANY | May 8, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | Split 35 FOR, 10 AGAINST |
FOR 21 funds |
| COLUMBIA SPORTSWEAR COMPANY | June 10, 2026 | To approve the Columbia Sportswear Company Amended and Restated 2020 Stock Incentive Plan. Compensation |
Board | For | Split 15 FOR, 7 AGAINST |
AGAINST 7 funds |
| COMCAST CORPORATION | June 10, 2026 | Advisory vote on executive compensation Say-on-Pay |
Board | For | Split 28 FOR, 12 AGAINST |
AGAINST 28 funds |
| COMERICA INCORPORATED | January 6, 2026 | Proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Comerica's named executive officers in connection with the first merger. Say-on-Pay |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 10 funds |
| COMMERCE.COM, INC. | May 14, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 12 FOR, 2 AGAINST |
FOR 9 funds |
| COMMUNITY HEALTH SYSTEMS, INC. | May 12, 2026 | Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 12 FOR, 2 AGAINST |
FOR 9 funds |
| COMPASS DIVERSIFIED HOLDINGS | May 21, 2026 | To ratify the appointment of Grant Thornton LLP to serve as the independent auditor for Compass Diversified Holdings and Compass Group Diversified Holdings LLC for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 9 funds |
| COMPASS MINERALS INTERNATIONAL, INC. | March 5, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
AGAINST 9 funds |
| CONCENTRIX CORPORATION | March 25, 2026 | Approval of an amendment to the Company's 2020 Stock Incentive Plan to increase the number of shares available for issuance. Compensation |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 7 funds |
| CONCENTRIX CORPORATION | March 25, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026; Audit-related |
Board | For | Split 18 FOR, 3 AGAINST |
FOR 7 funds |
| CONFLUENT, INC. | February 12, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | Split 17 FOR, 3 AGAINST |
FOR 5 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve an amendment and restatement of the Company's 2021 Stock Incentive Plan. Compensation |
Board | For | Split 11 FOR, 2 AGAINST |
FOR 9 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve, on an advisory basis, the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 11 FOR, 2 AGAINST |
FOR 9 funds |
| CONSOLIDATED WATER CO. LTD. | June 1, 2026 | The approval of a Special Resolution, attached as Exhibit B to the Proxy Statement, adopting an amendment to the Company's Amended and Restated Memorandum of Association relating to the increase of the share capital of the Company approved by Ordinary Resolution in Proposal 3. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 10 funds |
| CONSOLIDATED WATER CO. LTD. | June 1, 2026 | The approval of an Ordinary Resolution, attached as Exhibit A to the Proxy Statement, authorizing an increase of the share capital of the Company from (i) CI$12.5 million divided into 24,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50 each to (ii) CI$25 million divided into 49,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 10 funds |
| CONSTELLATION BRANDS, INC. | July 15, 2025 | To approve, by an advisory vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 32 FOR, 3 AGAINST |
FOR 17 funds |
| CONSTRUCTION PARTNERS INC | March 24, 2026 | Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders. Craig Jennings Director Elections |
Board | For | Split 1 FOR, 12 WITHHOLD |
WITHHOLD 9 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Estimated Cap for Provision of Guarantee Extraordinary Transactions |
Board | For | Split 1 FOR, 5 AGAINST |
AGAINST 1 fund |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Grant of a General Mandate to the Board to Issue Shares Capital Structure |
Board | For | Split 5 FOR, 1 AGAINST |
AGAINST 1 fund |
| COOPER COMPANIES INC | April 7, 2026 | Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | Split 23 FOR, 6 AGAINST |
FOR 17 funds |
| COOPER-STANDARD HOLDINGS INC. | May 14, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm. Audit-related |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 9 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. Compensation |
Board | For | Split 14 FOR, 12 AGAINST |
AGAINST 5 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | Split 25 FOR, 5 AGAINST |
FOR 5 funds |
| CORE NATURAL RESOURCES, INC. | April 30, 2026 | Approval, on an Advisory Basis, of the Compensation Paid to Core Natural Resources, Inc.'s Named Executive Officers in 2025. Say-on-Pay |
Board | For | Split 20 FOR, 5 AGAINST |
FOR 6 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 10 FOR, 12 AGAINST |
AGAINST 10 funds |
| CORPAY, INC. | May 7, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 27 FOR, 10 AGAINST |
AGAINST 17 funds |
| CORPAY, INC. | May 7, 2026 | Ratify the re-appointment of Ernst & Young LLP as Corpay's independent public accounting firm for 2026. Audit-related |
Board | For | Split 22 FOR, 9 AGAINST |
FOR 17 funds |
| CORSAIR GAMING, INC. | June 16, 2026 | To ratify the selection, by the audit committee of our Board of Directors, of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 16 FOR, 3 AGAINST |
FOR 12 funds |
| COSTAR GROUP, INC. | June 23, 2026 | Proposal to approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 33 FOR, 8 AGAINST |
FOR 25 funds |
| COSTCO WHOLESALE CORPORATION | January 15, 2026 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | Split 39 FOR, 1 AGAINST |
FOR 28 funds |
| COTERRA ENERGY INC. | May 4, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Coterra's named executive officers that is based on or otherwise relates to the merger (the ''Advisory Compensation Proposal''); and Say-on-Pay |
Board | For | Split 31 FOR, 9 AGAINST |
FOR 19 funds |
| COURSERA, INC. | June 10, 2026 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 19 FOR, 2 AGAINST |
FOR 9 funds |
| CRANE NXT, CO. | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as the Company's independent auditors for 2026. Audit-related |
Board | For | Split 17 FOR, 9 AGAINST |
FOR 9 funds |
| CREXENDO INC | December 2, 2025 | To consider and vote upon a proposal for advisory approval of the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
AGAINST 9 funds |
| CRH PLC | May 7, 2026 | Disapplication of Pre-emption Rights Capital Structure |
Board | For | Split 43 FOR, 1 AGAINST |
FOR 18 funds |
| CRICUT, INC. | June 3, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | Split 8 FOR, 8 AGAINST |
AGAINST 9 funds |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; Say-on-Pay |
Board | For | Split 18 FOR, 2 AGAINST |
FOR 12 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Ali Behbahani, M.D. Director Elections |
Board | For | Split 2 FOR, 6 AGAINST |
AGAINST 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Douglas A. Treco, Ph.D. Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of H. Edward Fleming, Jr., M.D. Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 13 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Re-election of Maria Fardis, Ph.D. Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 13 funds |
| CROCS, INC. | June 9, 2026 | An advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 26 FOR, 8 AGAINST |
FOR 9 funds |
| CROCS, INC. | June 9, 2026 | Approval of the Crocs, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | Split 28 FOR, 1 AGAINST |
AGAINST 9 funds |
| CROWN CASTLE INC. | May 20, 2026 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 40 FOR, 2 AGAINST |
FOR 18 funds |
| CRYOPORT, INC. | June 5, 2026 | To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; Compensation |
Board | For | Split 11 FOR, 2 AGAINST |
AGAINST 9 funds |
| CSG SYSTEMS INTERNATIONAL, INC. | January 30, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of CSG in connection with the consummation of the merger; and Say-on-Pay |
Board | For | Split 23 FOR, 4 AGAINST |
FOR 17 funds |
| CURIOSITYSTREAM INC. | May 20, 2026 | To approve an amendment to the CuriosityStream Inc. 2020 Omnibus Incentive Plan (the Plan) to increase the number of shares of Common Stock authorized for issuance under the Plan from 10,725,000 shares of Common Stock to 11,725,000 shares of Common Stock. Compensation |
Board | For | Split 8 FOR, 2 AGAINST |
AGAINST 9 funds |
| CURIOSITYSTREAM INC. | May 20, 2026 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the Proxy Statement. Compensation |
Board | For | Split 5 FOR, 7 AGAINST |
AGAINST 9 funds |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Appointment of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026, and authorization of the Audit Committee to set the independent auditor's remuneration. Audit-related |
Board | For | Split 27 FOR, 3 AGAINST |
FOR 12 funds |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve a non-binding advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | Split 23 FOR, 2 AGAINST |
AGAINST 16 funds |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve an amendment to the Company's 2019 Stock Incentive Plan. Compensation |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 16 funds |
| CVR ENERGY, INC. | June 4, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 26 FOR, 2 AGAINST |
AGAINST 14 funds |
| CYTOMX THERAPEUTICS, INC. | June 17, 2026 | To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares; Capital Structure |
Board | For | Split 7 FOR, 2 AGAINST |
FOR 3 funds |
| Camping World Holdings, Inc. | May 21, 2026 | Election of Class I Directors: K. Dillon Schickli Director Elections |
Board | For | Split 10 FOR, 1 WITHHOLD |
WITHHOLD 9 funds |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Brian J. Brille Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Danny Phillips Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: David Dean Halbert Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: David Frederickson Director Elections |
Board | For | Split 4 FOR, 8 WITHHOLD |
FOR 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Jeffrey Vacirca, M.D. Director Elections |
Board | For | Split 4 FOR, 8 WITHHOLD |
FOR 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Jon S. Halbert Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Joseph E. Gilliam Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Laura I. Johansen Director Elections |
Board | For | Split 4 FOR, 8 WITHHOLD |
FOR 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Lloyd B. Minor, M.D. Director Elections |
Board | For | Split 4 FOR, 8 WITHHOLD |
FOR 1 fund |
| Caris Life Sciences, Inc. | June 4, 2026 | Election of Directors: Peter M. Castleman Director Elections |
Board | For | Split 3 FOR, 9 WITHHOLD |
WITHHOLD 1 fund |
| Celanese Corporation | April 16, 2026 | Election of Directors: Deborah J. Kissire Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 3 funds |
| Celanese Corporation | April 16, 2026 | Election of Directors: Ganesh Moorthy Director Elections |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 3 funds |
| CenterPoint Energy, Inc. | April 16, 2026 | Election of Directors: Christopher H. Franklin Director Elections |
Board | For | Split 6 FOR, 13 AGAINST |
FOR 19 funds |
| CenterPoint Energy, Inc. | April 16, 2026 | Election of Directors: Dean L. Seavers Director Elections |
Board | For | Split 6 FOR, 13 AGAINST |
FOR 19 funds |
| CenterPoint Energy, Inc. | April 16, 2026 | Election of Directors: Thaddeus J. Malik Director Elections |
Board | For | Split 6 FOR, 13 AGAINST |
FOR 19 funds |
| CenterPoint Energy, Inc. | April 16, 2026 | Election of Directors: Theodore F. Pound Director Elections |
Board | For | Split 6 FOR, 13 AGAINST |
FOR 19 funds |
| CenterPoint Energy, Inc. | April 16, 2026 | Election of Directors: Wendy Montoya Cloonan Director Elections |
Board | For | Split 6 FOR, 13 AGAINST |
FOR 19 funds |
| Central Garden & Pet Company | February 11, 2026 | Election of Directors: Christopher T. Metz Director Elections |
Board | For | Split 3 FOR, 11 WITHHOLD |
WITHHOLD 13 funds |
| Centuri Holdings, Inc. | May 19, 2026 | Election of Directors: Anne L. Mariucci Director Elections |
Board | For | Split 10 FOR, 1 WITHHOLD |
WITHHOLD 5 funds |
← Previous Page 4 of 16 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.